Intranasal verapamil in allergen-induced rhinitis

Area of Science:

• Allergy and Immunology
• Pharmacology

Background:

• Allergic rhinitis affects many individuals globally.
• Calcium antagonists are being explored for their potential anti-allergic properties.

Purpose of the Study:

• To evaluate the efficacy of intranasal verapamil in mitigating allergen-provoked nasal symptoms in pollen-allergic subjects.

Main Methods:

• A double-blind, placebo-controlled trial involving 26 pollen-allergic participants.
• Administration of 1 mg intranasal verapamil versus placebo before allergen challenge.

Main Results:

• A statistically significant reduction in "tickling score" (22%, P<0.01) with verapamil.
• A non-significant reduction in sneezing (29%) was observed.
• No significant differences in nasal blockage or discharge between verapamil and placebo groups.

Conclusions:

• The tested verapamil nasal spray formulation did not demonstrate sufficient efficacy for clinical trials in allergic rhinitis.
• Further investigation into alternative calcium antagonist formulations is recommended to explore their therapeutic potential in allergic rhinitis.